Please enable JavaScript to view this site.

Rct-406

If you're looking for a specific type of review (e.g. technical, pros and cons, etc.), please let me know that as well. I'll do my best to provide a helpful review or point you in the direction of where you might find one.

Research indexed by ResearchGate identifies a major 2013 RCT (Inaba et al.) involving 406 patients focused on .

Below is an overview of the key clinical contexts where "1 RCT, 406 participants" (RCT-406) serves as a critical benchmark for medical evidence. 1. Antidepressant Efficacy: Paroxetine vs. Citalopram rct-406

: While efficacy varied, paroxetine was generally associated with a lower rate of adverse events compared to older tricyclic antidepressants like amitriptyline and imipramine. 2. Dementia Caregiving: The NYU-ADRC Study

: The inclusion of this 406-person study in meta-analyses helps healthcare providers determine the cost-effectiveness and clinical utility of remote patient monitoring technologies. Summary of RCT-406 Applications If you're looking for a specific type of review (e

A systematic review on telemonitoring for heart failure includes a pivotal 2006 RCT (Sisk et al.) with 406 participants.

: The study found that Paroxetine was significantly less effective than citalopram in improving patient response during the acute treatment phase (6 to 12 weeks). Research indexed by ResearchGate identifies a major 2013

: Evaluating whether telemonitoring could reduce hospitalization rates for heart failure patients.

: With 406 participants, the trial yielded a "number needed to treat" (NNTb) of 9, meaning approximately one in nine patients would see a better outcome specifically with citalopram over paroxetine.